Overweight & Obesity

Semaglutide reduces excess body fat in people with obesity

In adults with obesity or overweight, weekly treatment with the glucagon-like peptide 1 (GLP1) receptor agonist semaglutide leads to reduced excess body fat and increased lean body mass, according to an industry-sponsored ...

Overweight & Obesity

Patients' perspectives of clinical consultations related to weight

A recent review in Clinical Obesity assessed patients' reactions to consultations with physicians in which excess weight could have been or was discussed. In the review of 21 qualitative studies interviewing people who were ...

page 3 from 12